Palladium-Catalyzed Asymmetric Phosphination
Organometallics, Vol. 22, No. 16, 2003 3217
) 13, Ar), 136.8 (d, J ) 13, Ar), 132.9 (d, J ) 9, Ar), 132.3 (d,
J ) 3, Ar), 131.9 (d, J ) 8, Ar), 131.7 (Ar), 130.4 (d, J ) 2, Ar),
130.0 (d, J ) 3, Ar), 129.8 (d, J ) 57, Ar, quat), 129.0 (Ar),
128.9 (Ar), 128.8 (Ar), 128.7 (d, J ) 3, Ar), 128.58 (d, J ) 2,
Ar), 128.4 (Ar), 128.3 (Ar), 128.2 (Ar), 128.03 (Ar), 127.7 (Ar),
126.1 (d, J ) 45, Ar, quat), 124.2 (Ar), 120.0 (d, J ) 8, Ar),
109.9 (d, J ) 5, Ar), 54.5 (OMe), 36.8 (dd, J ) 27, 23, CH),
34.0 (dd, J ) 24, 15, CH), 14.4-13.9 (m, Me). 31P{1H} NMR
(CDCl3): δ 56.5 (d, J ) 39, B), 55.4 (d, J ) 36, A), 42.5 (d, J )
39, B), 41.8 (d, J ) 36, A). IR: 3036, 2966, 2907, 1560, 1482,
1449, 1431, 1219, 1102, 1055, 1020, 743, 690, 544, 520. Anal.
Calcd for C35H35IOP2Pd: C, 54.82; H, 4.60. Found: C, 54.83;
H, 4.71.
1H NMR (CDCl3): δ 8.47-8.42 (m, 1H B, Ar), 7.90-7.84 (m,
2H A, Ar), 7.66-7.59 (m, 3H B, Ar), 7.48-7.34 (m, 8H A, Ar),
7.17-7.12 (m, 1H B, Ar), 6.98-6.92 (m, 2H B, Ar), 6.91-6.83
(m, 2H B, Ar), 6.75-6.69 (m, 1H B, Ar), 6.67-6.60 (m, 1H A,
Ar), 6.48-6.44 (m, 1H B, Ar), 6.32-6.22 (m, 1H A, 1H B, Ar),
6.15-6.10 (m, 2H A, Ar), 5.74-5.69 (m, 1H B, Ar), 4.62-4.60
(m, 1H B, Cp), 4.54-4.51 (m, 1H A, Cp), 4.38-4.36 (m, 1H B,
Cp), 4.34-4.33 (m, 1H B, Cp), 4.26-4.25 (m, 1H A, Cp), 3.82-
3.78 (m, 6H A, Cp), 3.70 (5H B, Cp), 3.49-3.40 (m, 4H A, OMe,
CHMe), 3.20 (3H B, OMe), 3.17 (q, J HH ) 4, 1H B, CHMe),
2.14-2.09 (m, 3H A, Me), 2.10-2.06 (m, 3H B, Me), 1.76 (d,
J PH ) 12, 9H A, 9H B, t-Bu), 1.47 (d, J PH ) 13, 9H B, t-Bu),
1.38 (d, J PH ) 13, 9H A, t-Bu). 13C{1H} NMR (CDCl3): δ 160.7
(B, Ar, quat), 160.6 (d, J ) 3, A, Ar, quat), 141.4 (A, Ar), 138.0
(dd, J ) 138, 6, A, Ar, quat), 136.8 (d, J ) 15, B, Ar), 134.4 (d,
J ) 13, A, Ar), 134.0 (d, J ) 10, A, Ar), 132.8 (d, J ) 9, B, Ar),
132.3 (d, J ) 47, A, Ar, quat), 131.9 (d, J ) 63, A, Ar, quat),
130.1 (d, J ) 2, A, Ar), 129.6 (d, J ) 3, A, Ar), 128.2 (d, J )
11, B, Ar), 128.0 (B, Ar), 127.6 (d, J ) 20, A, Ar), 127.3 (d, J
) 11, A, Ar), 125.6 (d, J ) 10, B, Ar), 123.8 (B, Ar), 123.5 (A,
Ar), 120.3 (d, J ) 9, A, Ar), 108.6 (B, Ar), 107.9 (d, J ) 4, A,
Ar), 96.2 (dd, J ) 18, 7, A, Cp, quat), 79.1 (dd, J ) 35, 10, A,
Cp, quat), 74.8 (d, J ) 4, A, Cp, CH), 70.4 (B, Cp), 70.1 (A,
Cp), 69.3 (d, J ) 8, A, Cp, CH), 67.8 (A, Cp, CH), 53.7 (A, OMe),
53.2 (B, OMe), 39.5 (B, CMe3), 38.8 (A, CMe3), 38.3 (B, CMe3),
36.7 (d, J ) 2, A, CMe3), 33.7 (d, J ) 8, A, CH), 33.2 (br, B,
CMe3), 32.6 (d, J ) 4, A, CMe3), 31.4 (d, J ) 4, A, CMe3), 31.3
(B, CMe3), 19.0 (d, J ) 6, B, Me), 18.2 (d, J ) 6, A, Me). 31P-
{1H} NMR (CDCl3): δ 78.5 (d, J ) 38, A), 70.2 (d, J ) 36, B),
21.5 (d, J ) 36, B), 15.9 (d, J ) 38, A). IR: 2921, 2852, 1734,
1560, 1492, 1453, 1385, 1223, 1176, 1162, 1100, 1051, 1018,
746, 697. Anal. Calcd for C39H47FeIOP2Pd: C, 53.06; H, 5.37.
Found: C, 53.12; H, 5.39.
P d ((R)-Tol-Bin a p )(o-An )(I) (7). To a suspension of {Pd-
[P(o-Tol)3](o-An)(I)}2 (8; 390 mg, 0.302 mmol) in toluene (20
mL) was added a solution of (R)-Tol-Binap (410 mg, 0.605
mmol) in toluene (5 mL). The orange-brown suspension was
stirred at room temperature for 24-30 h, at which point it
appeared to be homogeneous. The solution was filtered by
cannula, and the filtrate was pumped dry. The granular off-
white solid contained a small amount of a purple impurity,
which was removed by washing with petroleum ether. Tritu-
ration with ether (75 mL) gave a yellow solid product. The solid
was then collected and recrystallized from THF/petroleum
ether at -25 °C to yield 308 mg of product (49%). Two
atropisomers (A and B), whose 1H NMR spectra were not
resolved in the aryl region, were observed in a 1.8:1 ratio.
1H NMR (C6D6): δ 8.65-8.63 (m, 1H B, Ar), 8.25-8.05 (m,
3H A, 3H B, Ar), 7.74 (m, 2H A, 2H B, Ar), 7.60-7.57 (m, 1H
A, 2H B, Ar), 7.33-7.20 (m, 2H A, 2H B, Ar), 7.12-6.90 (m,
11H A, 11H B, Ar), 6.82-6.77 (m, 2H A, 2H B, Ar), 6.65-6.53
(m, 6H A, 6H B, Ar), 6.23-6.21 (m, 3H A, 3H B, Ar) 6.10 (br,
2H A, 2H B, Ar), 3.67 (3H, B, OMe), 3.64 (3H, A, OMe), 2.09
(3H A, Me; 3H B, Me), 1.79-1.64 (overlapping s, 9H, A, Me;
9H, B, Me). 13C{1H} NMR (C6D6): δ 161.9 (Ar), 140.4 (m, Ar),
139.9-139.5 (m, Ar), 138.0-137.2 (m, Ar), 136.6 (m, Ar),
135.6-133.6 (m, Ar), 131.0-130.1 (m, Ar), 129.8 (Ar), 129.6-
129.4 (m, Ar), 127.0 (Ar), 126.8 (Ar), 126.4 (Ar), 124.6 (Ar),
123.9 (Ar), 122.6 (Ar), 121.0 (Ar), 114.0 (Ar), 111.7 (Ar), 110.5
(Ar), 56.0 (A, OMe), 55.9 (B, OMe), 21.7-21.3 (overlapping s,
tol-Me). 31P{1H} NMR (C6D6): δ 23.8 (d, J ) 37, A), 23.4 (d, J
) 38, B), 12.3 (d, J ) 37, A), 10.4 (d, J ) 38, B). IR: 3044,
2933, 1556, 1494, 1450, 1256, 1217, 1189, 1094, 1022, 800, 744,
700, 633, 522, 500. Anal. Calcd for C55H47IOP2Pd: C, 64.81;
H, 4.65. Found: C, 64.91; H, 4.63.
P d ((R,R)-Me-Du p h os)(o-An )(I) (5). A solution of Pd-
(TMEDA)(o-An)(I) (9; 255 mg, 0.558 mmol) and (R,R)-Me-
Duphos (171 mg, 0.558 mmol) in THF (3 mL) was stirred at
room temperature for 24 h. The yellow product was precipi-
tated by the addition of petroleum ether, collected, and further
washed with petroleum ether. Yield: 235 mg (65%). A sample
was prepared for elemental and crystallographic analysis by
recrystallization from CH2Cl2/Et2O at -25 °C. Complex 5
cocrystallized with 1 equiv of CH2Cl2 according to X-ray
crystallography. Desolvation occurred prior to elemental analy-
sis to yield a final Pd:CH2Cl2 ratio of 10:1. A 4.5:1 ratio of
atropisomers A and B was observed by NMR.
1H NMR (CDCl3): δ 7.75-7.67 (m, 1H A, 1H B, Ar), 7.64-
7.58 (m, 4H A, 3H B, Ar), 7.24-7.21 (m, 1H B, Ar), 6.97-6.92
(m, 1H A, 1H B, Ar), 6.83-6.80 (m, 1H A, 1H B, Ar), 6.67-
6.63 (m, 1H A, 1H B, Ar), 3.78-3.70 (m, 1H A, 1H B, CH),
3.74 (3H B, OMe), 3.72 (3H A, OMe), 3.16-3.09 (m, 1H B, CH),
2.89-2.78 (m, 1H A, CH), 2.65-2.60 (m, 1H B, CH), 2.57-
2.45 (m, 2H A, CH2), 2.39-2.29 (m, 1H A, 1H B, CH), 2.25-
1.80 (m, 6H A, 3CH2), 1.67-1.54 (9H B, Me + 3CH2), 1.57 (dd,
J PH ) 20, J HH ) 7, 3H A, Me), 1.44 (dd, J PH ) 19, J HH ) 7, 3H
A, Me), 1.24 (dd, J PH ) 20, J HH ) 7, 3H B, Me), 1.02-0.87 (m,
7H A, 2Me +CH; 6H B, 2Me), 0.81-0.77 (m, 2H B, CH2). 13C-
{1H} NMR (CDCl3): δ 163.5 (B, Ar), 162.0 (A, Ar), 144.7 (d, J
) 130, A, Ar, quat), 144.5 (dd, J ) 44, 34, A, Ar, quat), 143.0
(dd, J ) 33, 27, A, Ar, quat), 140.7 (A, Ar), 136.5 (B, Ar), 133.42
(d, J ) 9, B, Ar), 133.36 (d, J ) 15, A, Ar), 132.7 (d, J ) 16, A,
Ar), 132.6 (B, Ar), 131.5-131.3 (m, A, Ar), 124.4 (A, Ar), 120.8
(d, J ) 5, A, Ar), 111.5 (d, J ) 5, A, Ar), 109.6 (d, J ) 5, B,
Ar), 56.1 (A, OMe), 53.7 (B, OMe), 44.4 (d, J ) 29, A, CH),
43.0 (d, J ) 22, A, CH), 42.8 (d, J ) 23, B, CH), 42.7 (d, J )
28, B, CH), 38.0 (d, J ) 1, A, CH2), 37.8 (B, CH2), 37.5 (d, J )
21, B, CH), 36.8 (A, CH2), 36.7 (d, J ) 21, A, CH), 36.5 (B,
CH2), 36.3 (d, J ) 3, A, CH2), 35.9 (d, J ) 27, A, CH), 35.5 (d,
J ) 5, A, CH2), 35.4 (B, CH2), 33.6 (d, J ) 27, B, CH), 17.7 (d,
J ) 10, B, Me), 17.3 (d, J ) 11, A, Me), 16.1 (d, J ) 8, A, Me),
15.5 (B, Me), 15.0 (d, J ) 5, B, Me), 14.8 (A, Me), 14.7 (d, J )
18, B, Me), 14.2 (A, Me). 31P{1H} NMR (CDCl3): δ 74.8 (d, J
) 24, A), 73.8 (d, J ) 25, B), 69.0 (d, J ) 24, A), 68.6 (d, J )
25, B). IR: 3047, 2926, 2864, 1559, 1451, 1424, 1243, 1218,
1170, 1115, 1054, 1019, 753, 715, 698, 643, 545, 455. Anal.
Calcd for C25H35IOP2Pd‚0.1CH2Cl2: C, 46.01; H, 5.41. Found:
C, 45.94; H, 5.34.
P d ((R,S)-t-Bu -J osip h os)(o-An )(I) (6). A 50 mL ampule
was charged with Pd(TMEDA)(o-An)(I) (9; 250 mg, 0.547
mmol) and (R,S)-t-Bu-J osiphos (297 mg, 0.547 mmol) in 5 mL
of THF. The reaction flask was heated at 50 °C with stirring
under N2. The reaction was monitored by 31P{1H} NMR. After
24 h, the orange product precipitated out of solution. It was
collected and washed with petroleum ether. The mother liquor
was pumped dry, fresh THF was added, and heating was
continued. In this manner, the product was periodically
collected until its formation ceased (3 days). Yield: 414 mg
(85%). A sample was purified for elemental and crystal-
lographic analysis by recrystallization from CH2Cl2/Et2O at
-25 °C. Two atropisomers (A and B) were observed by NMR
in a 5:1 ratio.
Sep a r a tion of th e Dia ster eom er s of P d ((S,S)-Ch ir a -
p h os)(o-An )(P (Me)(P h )(BH3)) (11) a n d Isola tion of P u r e
P d ((S,S)-Ch ir a p h os)(o-An )(SP -P (Me)(P h )(BH3)) (11a ). Pd-
((S,S)-Chiraphos)(o-An)(I) (4; 300 mg, 0.391 mmol) was sus-
pended in toluene (4 mL) with vigorous stirring, and rac-
PH(Me)(Ph)(BH3) (2, 54 mg, 0.39 mmol) was added as a